RENAL TRANSPORT OF DRUGS: SPECIFICITY AND MOLECULAR MECHANISMS
- 1 November 1996
- journal article
- review article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 23 (10-11) , 986-989
- https://doi.org/10.1111/j.1440-1681.1996.tb01155.x
Abstract
1. The kidney is principally an excretory organ for drugs and their metabolites and has developed high capacity transport systems to rapidly eliminate the large quantities of foreign compounds delivered to it. 2. There are specific and selective transporters for organic cations and organic anions at the contraluminal and luminal membranes of the epithelial cells lining the proximal tubule. 3. For organic anions, the transporter (termed PAH-transporter) is located at the contraluminal cell membrane and uptake is a tertiary active transport process. Important physicochemical properties for interaction with this transporter are hydrophobicity, ionic charge strength and electron-attracting side groups. 4. For organic cations, there is evidence for one common transport system at the contraluminal membrane and substrate requirements are the degree of hydrophobicity, ionic charge strength and hydrogen bond formation. At the luminal membrane, an electroneutral H+/organic cation exchanger in which the degree of substrate hydrophobicity is critical for interaction and a choline transport system have been described. 5. P-Glycoprotein present in renal brush border membranes transports organic cationic drugs but is dissimilar to the luminal electroneutral H+/organic cation exchanger. 6. Clinically, several drugs have been implicated in causing interactions via these transport systems. For organic anions, probenecid blocks the tubular secretion of other organic anions and this has been used to prolong the duration of action of penicillin-like compounds. For organic cations, cimetidine and trimethoprim are potent inhibitors of the secretion of a number of organic cations, particularly procainamide, which can result in significant clinical toxicity. 7. An understanding of the mechanisms of renal tubular secretion of drugs and their metabolites will allow for the prediction of drug interactions involving renal excretory mechanisms.Keywords
This publication has 16 references indexed in Scilit:
- Specificity of transporters for ‘organic anions’ and ‘organic cations’ in the kidneyBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1994
- Bisubstrates: substances that interact with renal contraluminal organic anion and organic cation transport systemsPflügers Archiv - European Journal of Physiology, 1993
- Clinical Pharmacokinetic Significance of the Renal Tubular Secretion of DigoxinClinical Pharmacokinetics, 1987
- Dose and concentration dependent effect of ranitidine on procainamide disposition and renal clearance in man.British Journal of Clinical Pharmacology, 1984
- Use of the Isolated Perfused Kidney as a Tool in Drug Disposition StudiesDrug Metabolism Reviews, 1983
- Cimetidine-procainamide pharmacokinetic interaction in man: Evidence of competition for tubular secretion of basic drugsEuropean Journal of Clinical Pharmacology, 1983
- Renal Excretion of Drugs: Tubular Transport and MetabolismAnnual Review of Pharmacology, 1972
- STUDIES OF UREA EXCRETION. IIJournal of Clinical Investigation, 1928
- Versuche über den Vorgang der Harnabsonderung, in Verbindung mit Herrn stud. med. A. NeisserPflügers Archiv - European Journal of Physiology, 1874